Ingredient intelligence

Retinol

Retinoid · Retinol · C20H30O

CompareExplore biology

Retinol is a vitamin A alcohol that cells can convert to retinaldehyde and then retinoic acid, the form that binds nuclear retinoic acid and changes .

Replicated (3 studies)3 independent human studies in the curated set.

Any underlined term can be tapped for an everyday-English translation.

Molecular identity

Two-dimensional chemical structure of Retinol
Formula
C20H30O
Molecular weight
286.5 g/mol
PubChem CID
445354
ChEBI
CHEBI:17336
Open PubChem record →

Biological targets

  • Retinoic acid receptor alpha (RARA)

    high confidence

    activates · receptor

    Activated by the retinoic acid rather than retinol itself.

    UniProt P10276
  • Retinoic acid receptor gamma (RARG)

    high confidence

    activates · receptor

    UniProt P13631
  • Retinol dehydrogenase (RDH12)

    medium confidence

    targets · enzyme

    UniProt Q96NR8
  • Cellular retinol-binding protein 1 (RBP1)

    medium confidence

    targets · transporter

    UniProt P09455

Molecules & genes

Molecules

  • RetinolC20H30O · 286.5 g/mol
  • RetinaldehydeC20H28O · 284.4 g/mol
  • All-trans retinoic acidC20H28O2 · 300.4 g/mol

Genes / proteins

How could this ingredient interact with biology?

Biological network

Ingredient → molecule → target → gene/protein → pathway → process → studied outcome. Relationship strength is drawn from the curated confidence tier; nothing is added to make the chain look complete.

100%
RetinolRetinolRetinaldehydeAll-trans retinoic acidRetinoic acid receptor al…Retinoic acid receptor ga…Retinol dehydrogenase (RD…Cellular retinol-binding …RARARARGCOL1A1MMP1Retinoid metabolism and t…Nuclear receptor transcri…Extracellular matrix orga…Keratinocyte proliferationCollagen biosynthesisEpidermal cell turnoverStudied for photoaging-re…Studied for epidermal ren…Irritation and photosensi…

drag to pan · hover to isolate a path · click a node for detail

IngredientMoleculeTargetGenePathwayProcessOutcome
Text alternative for this network
  • Retinol is molecule Retinol — high confidence
  • Retinol is molecule Retinaldehyde — high confidence
  • Retinol is molecule All-trans retinoic acid — high confidence
  • Retinol activates Retinoic acid receptor alpha (RARA) — high confidence
  • Retinol activates Retinoic acid receptor gamma (RARG) — high confidence
  • Retinol targets Retinol dehydrogenase (RDH12) — medium confidence
  • Retinol targets Cellular retinol-binding protein 1 (RBP1) — medium confidence
  • Retinoic acid receptor alpha (RARA) encoded by RARA — high confidence
  • Retinoic acid receptor gamma (RARG) encoded by RARG — high confidence
  • RARA participates in Retinoid metabolism and transport — high confidence
  • RARG participates in Retinoid metabolism and transport — high confidence
  • COL1A1 participates in Retinoid metabolism and transport — medium confidence
  • MMP1 participates in Retinoid metabolism and transport — medium confidence
  • RARA participates in Nuclear receptor transcription pathway — high confidence
  • RARG participates in Nuclear receptor transcription pathway — high confidence
  • COL1A1 participates in Nuclear receptor transcription pathway — medium confidence
  • MMP1 participates in Nuclear receptor transcription pathway — medium confidence
  • RARA participates in Extracellular matrix organisation — medium confidence
  • RARG participates in Extracellular matrix organisation — medium confidence
  • COL1A1 participates in Extracellular matrix organisation — medium confidence
  • MMP1 participates in Extracellular matrix organisation — medium confidence
  • Retinoid metabolism and transport associated with Keratinocyte proliferation — high confidence
  • Nuclear receptor transcription pathway associated with Keratinocyte proliferation — high confidence
  • Extracellular matrix organisation associated with Keratinocyte proliferation — medium confidence
  • Retinoid metabolism and transport associated with Collagen biosynthesis — medium confidence
  • Nuclear receptor transcription pathway associated with Collagen biosynthesis — medium confidence
  • Extracellular matrix organisation associated with Collagen biosynthesis — medium confidence
  • Retinoid metabolism and transport associated with Epidermal cell turnover — high confidence
  • Nuclear receptor transcription pathway associated with Epidermal cell turnover — high confidence
  • Extracellular matrix organisation associated with Epidermal cell turnover — medium confidence
  • Keratinocyte proliferation studied in Studied for photoaging-related skin texture and wrinkling — medium confidence
  • Collagen biosynthesis studied in Studied for photoaging-related skin texture and wrinkling — medium confidence
  • Epidermal cell turnover studied in Studied for photoaging-related skin texture and wrinkling — medium confidence
  • Keratinocyte proliferation studied in Studied for epidermal renewal — medium confidence
  • Collagen biosynthesis studied in Studied for epidermal renewal — medium confidence
  • Epidermal cell turnover studied in Studied for epidermal renewal — medium confidence
  • Keratinocyte proliferation studied in Irritation and photosensitivity are commonly reported in studies — medium confidence
  • Collagen biosynthesis studied in Irritation and photosensitivity are commonly reported in studies — medium confidence
  • Epidermal cell turnover studied in Irritation and photosensitivity are commonly reported in studies — medium confidence

Biological pathways

Retinoid metabolism and transport

high confidence

Conversion and carrier-protein handling of retinol and its .

Reactome R-HSA-975634

Nuclear receptor transcription pathway

high confidence

/RXR heterodimers bind retinoic acid response elements and alter .

Reactome R-HSA-383280

Extracellular matrix organisation

medium confidence

and matrix-metalloproteinase changes reported in retinoid-treated skin.

Reactome R-HSA-1474244

Evidence engine

Strong

Multiple independent human studies point in the same direction.

Skinceptor Evidence Index

75

experimental · of 100

This index is a research-navigation aid describing how much evidence exists and how it was produced. It is not a medical safety score, an efficacy guarantee, or a clinical recommendation.

Study composition

  • Human1
  • Randomised controlled trial2
  • In-vitro1
  • Review2
Total studies
6
Human studies
3
Largest sample
44
Range
1999–2019

Index breakdown

  • Study design quality61% × 28%

    Mean design weight across curated studies (meta-analysis 1.0, RCT 0.9, other human 0.7, review 0.45, animal 0.35, in-vitro 0.25).

  • Human evidence share100% × 22%

    Proportion of curated evidence measured in people rather than cells or animals.

  • Evidence volume89% × 14%

    Log-scaled count of curated studies, so volume alone cannot dominate the score.

  • Largest sample size55% × 12%

    Log-scaled largest reported sample size across curated human studies.

  • Replication100% × 12%

    Independent human studies, capped at three; one study is never treated as replicated.

  • Recency65% × 7%

    Linear decay over a twenty-year window from the most recent curated publication.

  • Source traceability17% × 5%

    Share of curated studies with a verified PMID or DOI in this dataset.

How is this determined? →

Insufficient comparable evidence for quantitative synthesis.

Research timeline

How the evidence accumulated

  1. 1999

    Retinaldehyde: cutaneous conversion to retinoic acid and tolerability in human skin

    Reviewsample size unavailable · Dermatology (review)

  2. 2000

    Retinoid-induced procollagen synthesis and matrix metalloproteinase suppression in human skin in vivo

    Humann = 22 · Journal of Clinical Investigation

  3. 2007

    Retinol improves the appearance of naturally aged skin

    Randomised controlled trialn = 36 · Archives of Dermatology

  4. 2015

    Retinoic acid receptor expression and retinoid signalling in human skin

    Reviewsample size unavailable · Journal of Investigative Dermatology (review)

  5. 2018

    Hydroxypinacolone retinoate: receptor binding without prior conversion

    In-vitrosample size unavailable · International Journal of Cosmetic Science

  6. 2019

    Prospective randomized double-blind assessment of topical bakuchiol and retinol for facial photoaging

    Randomised controlled trialn = 44 · British Journal of Dermatology

Ingredient fingerprint

21 nodes · 41 relationships · seed "retinol"

The fingerprint is a deterministic visual signature: ridge amplitude comes from the number of entities in each tier, node placement from identifier hashes, and opacity from confidence. Two ingredients can never produce the same figure unless their networks are identical.

Open in Biology as Art →

Research

6 curated studies

Randomised controlled trialBritish Journal of Dermatology · 2019n = 44

Prospective randomized double-blind assessment of topical bakuchiol and retinol for facial photoaging

Reported comparable improvement in wrinkle and pigmentation scores between bakuchiol and retinol, with less scaling and stinging reported for bakuchiol.

Limitations — Single centre, 12 weeks, no vehicle arm, so both may reflect regression to the mean.

PMID 29752709Bakuchiol · Retinol
In-vitroInternational Journal of Cosmetic Science · 2018

Hydroxypinacolone retinoate: receptor binding without prior conversion

Reported direct retinoic acid receptor binding for the ester, in contrast to retinol which requires cutaneous conversion.

Limitations — Binding assays only; no controlled human comparison against retinol; identifier not verified during curation.

Identifier not curated — search Europe PMCHydroxypinacolone retinoate · Retinol
ReviewJournal of Investigative Dermatology (review) · 2015

Retinoic acid receptor expression and retinoid signalling in human skin

Summarises RAR/RXR heterodimer signalling as the transcriptional mechanism of retinoid action in epidermis and dermis.

Limitations — Narrative review; mechanistic focus without effect-size synthesis.

Identifier not curated — search Europe PMCRetinol · All-trans retinoic acid · Retinaldehyde
Randomised controlled trialArchives of Dermatology · 2007n = 36

Retinol improves the appearance of naturally aged skin

Reported improvement in fine wrinkling with topical retinol versus vehicle in older adults.

Limitations — Small sample; older cohort limits generalisation; identifier not verified during curation.

HumanJournal of Clinical Investigation · 2000n = 22

Retinoid-induced procollagen synthesis and matrix metalloproteinase suppression in human skin in vivo

Reported increased procollagen I expression and reduced MMP-1 in biopsied retinoid-treated skin.

Limitations — Biopsy-based surrogate endpoints; identifier not verified during curation.

Identifier not curated — search Europe PMCAll-trans retinoic acid · Retinol
ReviewDermatology (review) · 1999

Retinaldehyde: cutaneous conversion to retinoic acid and tolerability in human skin

Summarises evidence that retinaldehyde is oxidised in skin to retinoic acid, with reported tolerability intermediate between retinol and tretinoin.

Limitations — Narrative review; identifier not verified during curation.

Identifier not curated — search Europe PMCRetinaldehyde · Retinol · All-trans retinoic acid

Community evidence

Submitted by readers

Submit a study

Reader submissions appear here only after review. They are not part of the curated dataset and do not affect the Skinceptor Evidence Index.

No approved community submissions yet.

Sources